Scandinavian Chemotech: Positive cash flow in Animal Care - Redeye

Redeye provides a comment on today's news from Scandinavian Chemotech, where the company announced that the Animal Care segment, on a standalone basis, showed positive cash flow for 2024. We are positive about the announcement, but await the quarterly report, due on March 4, before making any firm changes to our estimates and valuation.

Länk till analysen i sin helhet: https://www.redeye.se/research/1068796/scandinavian-chemotech-positive-cash-flow-in-animal-care?utm_source=finwire&utm_medium=RSS